| Molecular docking and structure-based drug design strategies LG Ferreira, RN Dos Santos, G Oliva, AD Andricopulo Molecules 20 (7), 13384-13421, 2015 | 1593 | 2015 |
| ADMET modeling approaches in drug discovery LLG Ferreira, AD Andricopulo Drug discovery today 24 (5), 1157-1165, 2019 | 325 | 2019 |
| Virtual screening and its integration with modern drug design technologies AD Andricopulo, RVC Guido, G Oliva Current medicinal chemistry 15 (1), 37-46, 2008 | 269 | 2008 |
| Structure-based drug design strategies in medicinal chemistry AD Andricopulo, LB Salum, DJ Abraham Current topics in medicinal chemistry 9 (9), 771-790, 2009 | 200 | 2009 |
| Development of a natural products database from the biodiversity of Brazil M Valli, RN Dos Santos, LD Figueira, CH Nakajima, I Castro-Gamboa, ... Journal of Natural Products 76 (3), 439-444, 2013 | 174 | 2013 |
| NuBBEDB: an updated database to uncover chemical and biological information from Brazilian biodiversity AC Pilon, M Valli, AC Dametto, MEF Pinto, RT Freire, I Castro-Gamboa, ... Scientific Reports 7 (1), 7215, 2017 | 160 | 2017 |
| Quimioterapia da doença de Chagas: estado da arte e perspectivas no desenvolvimento de novos fármacos LC Dias, MA Dessoy, JJN Silva, OH Thiemann, G Oliva, AD Andricopulo Química Nova 32, 2444-2457, 2009 | 150 | 2009 |
| Planejamento de fármacos, biotecnologia e química medicinal: aplicações em doenças infecciosas RVC Guido, AD Andricopulo, G Oliva Estudos avançados 24, 81-98, 2010 | 139 | 2010 |
| Synthesis, biological evaluation, and molecular modeling of chalcone derivatives as potent inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatases (PtpA and PtpB) LD Chiaradia, PGA Martins, MNS Cordeiro, RVC Guido, G Ecco, ... Journal of medicinal chemistry 55 (1), 390-402, 2012 | 114 | 2012 |
| Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth A Mascarello, LD Chiaradia, J Vernal, A Villarino, RVC Guido, P Perizzolo, ... Bioorganic & medicinal chemistry 18 (11), 3783-3789, 2010 | 112 | 2010 |
| Novel ruthenium complexes as potential drugs for Chagas's disease: enzyme inhibition and in vitro/in vivo trypanocidal activity JJN Silva, PMM Guedes, A Zottis, TL Balliano, FO Nascimento Silva, ... British journal of pharmacology 160 (2), 260-269, 2010 | 104 | 2010 |
| Hologram QSAR model for the prediction of human oral bioavailability TL Moda, CA Montanari, AD Andricopulo Bioorganic & medicinal chemistry 15 (24), 7738-7745, 2007 | 100 | 2007 |
| N4-Phenyl-substituted 2-acetylpyridine thiosemicarbazones: Cytotoxicity against human tumor cells, structure–activity relationship studies and investigation on the mechanism of … MA Soares, JA Lessa, IC Mendes, JG Da Silva, RG Dos Santos, LB Salum, ... Bioorganic & medicinal chemistry 20 (11), 3396-3409, 2012 | 99 | 2012 |
| Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors RF Freitas, IM Prokopczyk, A Zottis, G Oliva, AD Andricopulo, ... Bioorganic & medicinal chemistry 17 (6), 2476-2482, 2009 | 99 | 2009 |
| Synthesis and reactivity of β-amino α, β-unsaturated ketones and esters using K-10 montmorillonite MEF Braibante, HS Braibante, L Missio, A Andricopulo Synthesis 1994 (09), 898-900, 1994 | 99 | 1994 |
| Fragment-based QSAR: perspectives in drug design LB Salum, AD Andricopulo Molecular diversity 13, 277-285, 2009 | 97 | 2009 |
| Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents AD Andricopulo, MB Akoachere, R Krogh, C Nickel, MJ McLeish, ... Bioorganic & medicinal chemistry letters 16 (8), 2283-2292, 2006 | 95 | 2006 |
| Discovery of New Inhibitors of Mycobacterium tuberculosis InhA Enzyme Using Virtual Screening and a 3D-Pharmacophore-Based Approach I Pauli, RN Dos Santos, DC Rostirolla, LK Martinelli, RG Ducati, ... Journal of chemical information and modeling 53 (9), 2390-2401, 2013 | 90 | 2013 |
| Synthesis, Biological Evaluation, and Structure–Activity Relationships of Potent Noncovalent and Nonpeptidic Cruzain Inhibitors as Anti-Trypanosoma cruzi Agents RS Ferreira, MA Dessoy, I Pauli, ML Souza, R Krogh, AIL Sales, G Oliva, ... Journal of medicinal chemistry 57 (6), 2380-2392, 2014 | 89 | 2014 |
| Biochemical evaluation of a series of synthetic chalcone and hydrazide derivatives as novel inhibitors of cruzain from Trypanosoma cruzi DM Borchhardt, A Mascarello, LD Chiaradia, RJ Nunes, G Oliva, ... Journal of the Brazilian Chemical Society 21, 142-150, 2010 | 88 | 2010 |
